Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Core EBITDA Growth

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 7.7642.48-15.611.9932.11

What is the latest Core EBITDA Growth ratio of AJANTA PHARMA ?

The latest Core EBITDA Growth ratio of AJANTA PHARMA is 7.76 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20257.76
Mar202442.48
Mar2023-15.61
Mar20221.99
Mar202132.11

How is Core EBITDA Growth of AJANTA PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 7.76
-81.73
Mar2024 42.48
Positive
Mar2023 -15.61
Negative
Mar2022 1.99
-93.80
Mar2021 32.11 -

Other Financial Ratios of AJANTA PHARMA


Compare Core EBITDA Growth ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹30,143.4 Cr -1% -5.1% -23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,791.0 Cr 1.2% 4.2% -10.9% Stock Analytics
DIVIS LABORATORIES ₹174,885.0 Cr -0.5% 8.9% 10.8% Stock Analytics
CIPLA ₹127,930.0 Cr 0.4% 3.7% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,108.0 Cr -0% -2.1% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,164.0 Cr 2.2% -1.8% -4.4% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-1%

-5.1%

-23.1%

SENSEX

0.9%

2.5%

3.7%


You may also like the below Video Courses